clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04278898 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P767 | contributor to the creative work or subject | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
P582 | end time | 2022-08-01 | |
P921 | main subject | electroencephalography | Q179965 |
P4135 | maximum age | 12 | |
P1050 | medical condition | autism spectrum disorder | Q1436063 |
P2899 | minimum age | 3 | |
P1132 | number of participants | 24 | |
P4844 | research intervention | acetylcysteine | Q375613 |
N-monoacetylcystine | Q27294771 | ||
P859 | sponsor | Stanford University | Q41506 |
P580 | start time | 2020-04-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: a Single-dose Challenge Study |